Cayman Funds and Advent Co-Invest Fund, the “Advent Funds.” Wilco GP, an affiliate of Advent, is the General Partner of Wilco Acquisition. Advent is the manager of Advent Top GC, which in turn is the General Partner of each of Advent GP Cayman, the Advent AP Funds, and the Advent Co-Invest Fund. Advent Top GC is also the manager of Advent GP Luxembourg, which is the General Partner of each of the Advent Luxembourg Funds. Advent GP Cayman is the General Partner of each of the Advent Cayman Funds. The general partner of Advent is managed by a board of managers that is comprised of James Brocklebank, John Maldonado, and David Mussafer (the “Advent Board”).
The address of the principal business and the principal office of the Reporting Persons is Prudential Tower, 800 Boylston Street, Boston, Massachusetts 02199-8069.
During the last five years, none of the Reporting Persons or, to the knowledge of the Reporting Persons, any of the members of the Advent Board or the persons listed on Schedule A attached hereto have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. A joint filing agreement among the Reporting Persons is attached as Exhibit 1 to this Statement and incorporated herein by reference.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
Item 6 of the Schedule 13D is hereby amended to include the following at the end thereof:
Non-Tender Agreement
On December 14, 2024 the Reporting Persons entered into a non-tender agreement with the Issuer (the “Non-Tender Agreement”), pursuant to which the Reporting Persons have agreed that they will not tender any shares in connection with the Issuer’s announced tender offer to purchase up to 1,650,000 shares of its Class A Common Stock at a purchase price of $2.85 per Share, net to the seller in cash, without interest thereon and subject to any tax withholding. This description of the Non-Tender Agreement is qualified in its entirety by the full text of such agreement, which is attached hereto as Exhibit 2.
Item 7. Material to be Filed as Exhibits
| | |
Exhibit 1 | | Joint filing agreement, dated as of December 17, 2024. |
| |
Exhibit 2 | | Non-Tender Agreement, dated as of December 14, 2024, by and among ATI Physical Therapy, Inc. and the Reporting Persons (filed as Exhibit d to the Issuer’s Schedule to Tender Offer Statement on December 17, 2024, and incorporated herein by reference). |